Organogenesis Holdings Inc.

Organogenesis Holdings Inc. (Nasdaq: ORGO) is a regenerative medicine company specializing in advanced wound care products that reached the public markets through a business combination with Avista Healthcare Public Acquisition Corp., a SPAC sponsored by healthcare-focused private equity firm Avista Capital Holdings, which closed in December 2018. The company filed an amended registration statement (S-1/A) with the SEC on November 10, 2020, accession number 0001193125-20-290330, as part of its post-merger capital markets activity. Operating in the healthcare and medical technology sector, Organogenesis develops and commercializes bioactive and acellular wound care solutions for both chronic and acute conditions. Visit SpacDesk and sign up for full filing history, deal timelines, and comprehensive SPAC data on ORGO and hundreds of other transactions.